Essity Enhances Global Athletics Tape Production Capacity
Essity's Expansion of Athletics Tape Production
Essity, a leading hygiene and health company, is excited to announce the expansion of its athletics tape production capabilities. This initiative involves a substantial investment in a new production line dedicated to its popular product, Leukotape K. This development aims to significantly increase the production capacity to cater to the rising demand for high-quality athletic tape around the globe.
What is Leukotape K?
The Benefits of Leukotape K
Leukotape K is an innovative elastic kinesiology tape that has become crucial for athletes recovering from injuries or managing pain during various physical activities. It is designed to provide support, alleviate discomfort, and promote healing for both amateur and professional sports enthusiasts. The versatility of Leukotape K means it is widely utilized not only in sports settings but also within clinical environments, aiding a diverse range of individuals.
Production Capacity Impact
The new, fully automated production line will be set up at Essity's facility in Vibraye, France. This state-of-the-art facility aims to quintuple the current production capacity of Leukotape K. With an impressive investment of EUR 1 million, the facility is poised to produce over 10 million square meters of elastic adhesive tape each year, which is equivalent to covering around 1,400 football fields. This capacity supports Essity's extensive range of medical solutions under various brands, including Actimove, Leukoplast, and Tensoplast.
Essity's Commitment to Quality
Ulrika Kolsrud, President of Health & Medical at Essity, expressed pride in the expansion, emphasizing the company’s dedication to high-quality medical solutions. She stated, "Leukotape K enables recovery from injury and helps manage pain during demanding sports. This expansion reinforces our commitment to supporting athletes at every level, ensuring their performance and well-being."
Essity's Position in the Market
As the world’s third-largest player in non-invasive orthopedic products, Essity offers a wide range of solutions for skeletal, muscular, and joint injuries, as well as chronic conditions like arthritis. The comprehensive product assortment includes innovative offerings such as casts, splints, support braces, and athletic tapes tailored to meet the needs of various users.
For further inquiries, please reach out to:
Karl Stoltz
Media Relations Director
+46 709 42 63 88
Frequently Asked Questions
What is the focus of Essity's expansion?
Essity is focusing on expanding its production of Leukotape K, which is an elastic kinesiology tape used in sports and medical settings.
How will the new production line benefit the company?
The new production line will significantly increase the manufacturing capacity of Leukotape K by fivefold, allowing Essity to meet growing global demand.
What are the applications of Leukotape K?
Leukotape K is used to relieve pain, assist in treating swelling, and enhance overall function for athletes and patients alike.
Where is the new production facility located?
The fully automated facility is located at Essity's site in Vibraye, France.
How does Essity rank in the orthopedic products market?
Essity is recognized as the world's third-largest producer of non-invasive orthopedic products, offering a comprehensive range of solutions for various injuries and chronic conditions.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
